|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/513 | |||
| A61K 31/655 | |||
| A61K 31/7072 | |||
| A61K 31/7088 | |||
| A61P 35/00 | |||
| C07K 14/71 | |||
| A61K 45/06 |
| (11) | Number of the document | 2793925 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12809999.1 |
| Date of filing the European patent application | 2012-12-19 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/070571 |
| Date | 2012-12-19 |
| (87) | Number | WO 2013/106175 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201113329897 | 2011-12-19 | US |
| (72) |
SUN, Jeonghoon, US
TAM, Lei-Ting Tony, US
HAN, Huiquan, US
KWAK, Keith Soo-Nyung, US
ZHOU, Xiaolan, US
LU, John, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (54) | VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF |
| VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF |